Work

Abstract 4778: ADCE-T02: A first-in-class topoisomerase-1 inhibitor based antibody drug conjugate against tissue factor demonstrates excellent preclinical efficacy and tolerability

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-4778

Authors: Thomas Tuxen Poulsen, Yue Zhang, Jianjian Zhang, Huiyan Shi, Shu-Hui Liu, Xun Meng, Mette Gillberg, Dominik Mumberg

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409629067

Cites:

Cited by:

Related to: 10